Clinical Trials Directory

Trials / Sponsors / Research Institute for Biological Safety Problems

Research Institute for Biological Safety Problems

Other Government · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedReactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine
Covid19, SARS-CoV Infection, Vaccine Adverse Reaction
Phase 1 / Phase 22021-06-15
CompletedImmunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine
Covid19, SARS-CoV Infection, Vaccine Adverse Reaction
Phase 32020-12-25
CompletedReactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine
Covid19, SARS-CoV Infection, Vaccine Adverse Reaction
Phase 1 / Phase 22020-09-19
CompletedPreventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccin
Human Influenza
Phase 32017-09-18
CompletedImmunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)
Influenza
Phase 22016-10-01
CompletedReactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine
Influenza, Human
Phase 12016-05-01
CompletedReactogenicity, Safety and Immunogenicity of a TB/FLU-01L Tuberculosis Vaccine
Tuberculosis
Phase 12013-10-01
CompletedReactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine
Tuberculosis
Phase 12013-10-01